Velpatasvir
Velpatasvir (Epclusa) is an antiviral ingredient used to treat chronic hepatitis C. This page lists the one tablet formulation available in the catalogue.
Key points
- Velpatasvir is paired with sofosbuvir in a single tablet, combining two antivirals in one dose.
- Epclusa is the originator brand; Velpanat is the generic listed in this catalogue, manufactured by Natco Pharma.
About this ingredient
The ingredient velpatasvir is an antiviral from the Antivirals class that works by blocking a protein the hepatitis C virus needs to reproduce. It is used for Chronic Hepatitis C. When paired with sofosbuvir in the tablet Velpanat, the combination reduces the virus level in the body, supporting the liver’s recovery over the course of treatment. The generic is manufactured by Natco Pharma and is listed as equivalent to the originator brand Epclusa.